kras g12v mutant advanced epithelial cancers

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

KRAS G12V Mutant Advanced Epithelial Cancers Trial (Cyclophosphamide, Gemcitabine, Pembrolizumab)

Available
  • KRAS G12V Mutant Advanced Epithelial Cancers
  • (no location specified)
May 19, 2022